Mark Wellington cherished the final years he spent with his wife after she was diagnosed with multiple myeloma. Now he wants Pharmac to make good on...
Myeloma NZ
Newsletter: January 2020
Happy New Year to everybody. It was a very busy and productive year in 2019. Thanks to everyone who has contributed in so many different ways. The...
Myeloma NZ calls on Pharmac to make good on access deal
Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer treatment lenalidomide (Revlimid)...
Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer
Media Release In a move welcomed by patient advocacy group Myeloma New Zealand, drug buying agency Pharmac has proposed to widen access to blood...
Multiple Myeloma Research Review
Highlights include: • Once-weekly vs twice weekly carfilzomib for newly diagnosed MM • Negative trials for pembrolizumab in treatment naive and...
Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma
Results from a new study at Hutchinson Cancer Research Cancer in Seattle suggests that chimeric antigen receptor (CAR) T-cell therapy can be further...
Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’
The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent Cancer Control Agency was formally opened on Tuesday....
Major developments in multiple myeloma to be presented at ASH
Starting Saturday, December 7, HemOnc Today will be onsite in Orlando at the ASH Annual Meeting and Exposition, bringing the latest in important,...
Myeloma Medicines Applications: The status of medicines applications for myeloma currently with Pharmac
A summary of events and the status of medicines applications for myeloma currently with Pharmac  Tania Crosbie Special Projects Manager, Myeloma...
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
The objective of the study was to assess racial disparities in the treatment and outcomes among white, African American, and Hispanic patients with...
Myeloma New Zealand Christmas Function
Ken Romeril, CEO Myeloma New Zealand Charitable Trust invites you to the Myeloma New Zealand Christmas Function. Wednesday 11 December, 5.00pm at...
Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget
There are issues involving Pharmac and how they fund medicines - Pharmac does not adopt international guidelines; it does not set a timeframe by...